Academic research of new drugs for new targets can raise a host of different intellectual property considerations.  US and foreign intellectual property strategies for new drugs and drug formulations that maximize the value of research in terms of breadth and length of patent protection are discussed.  Also discussed are strategies for optimizing a drug research program to improve the likelihood of patent protection for future developments without sacrificing the breadth of protection of the initial drug research.

Patenting strategies for new drug development: Considerations for maximizing protection of academic research

247th National Meeting (2014)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.